DOCSLIB.ORG

Feto-Placental Interactions and Metabolic and Nutritive Status Pascale Chavatte-Palmer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Feto-Placental Interactions and Metabolic and Nutritive Status Pascale Chavatte-Palmer Feto-placental interactions and metabolic and nutritive status Pascale Chavatte-Palmer To cite this version: Pascale Chavatte-Palmer. Feto-placental interactions and metabolic and nutritive status. 66. Annual Scientific Meeting of the Society for Reproductive Investigation, Society for Reproductive Investiga- tion., Mar 2019, Paris, France. hal-02077522 HAL Id: hal-02077522 https://hal.archives-ouvertes.fr/hal-02077522 Submitted on 4 Jun 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. FINAL PROGRAM — From Innovation to Impact — Society for Reproductive Investigation 66th Annual Scientific Meeting March 12 - 16, 2019 PARIS, FRANCE The SRI 66th Annual Scientific Meeting has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) March 12 – 16, 2019 • Palais des Congrès de Paris, Paris, France 1 Table of Contents Message from the SRI President . 1 2019 Program Committee . 2 General Meeting Information . 3 Meeting Attendance Code of Conduct Policy . 4 Schedule-at-a-Glance . 5 Meeting Information and Social Events . 6 Exhibitors . 7 Palais des Congrès de Paris Floor Plan . 8 Hyatt Regency Paris Étoile Floor Plan . 9 Continuing Medical Education Information . 11 Scientific Program . 12 Thank You to Our 2019 Poster Judges . 55 SRI Grant Opportunities . .56 2019 Awards . 57 About SRI . .59 . SRI Council & Staff . 61 Poster Guide . 62 Oral and Poster Abstract Author Index . 108 Notes . 133 SRI Thanks Its 2019 Supporters . Inside Back Cover Save the Date: SRI 2020 Annual Meeting . Back Cover SRI 66th Annual Scientific Meeting Venue SRI 66th Annual Scientific Meeting Host Hotel Palais des Congrès de Paris Hyatt Regency Paris Étoile 2 Place de la Porte Maillot 3, Place du Général Kœnig 75853 Paris Cedex 17 Paris, 75017, FR Phone: +33 (0)1 40 68 22 22 Phone: +33 (0)1 40 68 12 34 Future SRI Annual Scientific Meetings SRI 67th Annual Scientific Meeting • Vancouver, BC, Canada • March 10 – 14, 2020 SRI 68th Annual Scientific Meeting • Boston, MA • March 23 – 27, 2021 SRI 69th Annual Scientific Meeting • Denver, CO • March 15 – 19, 2022 SRI 70th Annual Scientific Meeting • Brisbane, Australia • March 21 - 25, 2023 Society for Reproductive Investigation 555 East Wells Street, Suite 1100 Milwaukee, WI 53202-3823 Phone: +1-414-918-9888 Fax: +1-414-276-3349 Email: info@sri-online .org Website: www .sri-online .org © Society for Reproductive Investigation . All Rights Reserved . 2 SOCIETY FOR REPRODUCTIVE INVESTIGATION • 66th Annual Scientific Meeting Message from the SRI President Dear Colleagues, Welcome to the 66th Annual Meeting of the Society for Reproductive Investigation (SRI), which is being held from Tuesday, March 12th to Saturday, March 16th in Paris, France . This will be the third Annual Meeting held outside of North America and builds upon our successful meetings in Glasgow and Florence . We have chosen the theme of “From Innovation to Impact ”. This highlights the Society’s dedication not only to world-class innovation in basic research and translational medicine, but also to improvements in women’s reproductive health and healthcare . With Sarah England, PhD as Program Director, we have developed an outstanding programme that includes two Presidential Distinguished Lecturers, the President’s New Investigator Plenary Session, sponsored by the SRI Past Presidents’ Fund, 24 concurrent oral sessions and 12 mini symposia . We have an exciting programme of Lunch and Learn sessions including one dedicated to the exciting topic of genome editing and the future of reproduction . Our first Presidential Distinguished Lecturer is Dennis Lo, FRS, Associate Dean (Research) of the Faculty of Medicine, the Director of the Li Ka Shing Institute of Health Sciences and Chairman of the Department of Chemical Pathology of The Chinese University of Hong Kong . He will be speaking on the “Plasma Nucleic Acids in Health and Disease ”. On Thursday, March 14th at 8:00 a .m . Our second Presidential Distinguished Lecturer, Edith Heard, FRS, Director General of the European Molecular Biology Laboratory (EMBL) and leader of the Mammalian Developmental Epigenetics team at the Institut Curi, will speak on Friday, March 15th at 8:00 a .m . Her talk is entitled “Exploring Epigenetic Dynamics During Mammalian Development Using X-chromosome Inactivation” . In addition to the scientific sessions, we also a host Career Development activities including an afternoon Career Development Workshop on Tuesday, followed by Mentor-in-a-Cloud, a New Investigator Forum and a Mid-Career Development Session on Wednesday . We will continue our highly successful Connection Corners on Thursday evening . Finally, the traditional satellites will continue to fill Wednesday . We received a record number of over 40 submissions for mini symposia ideas . They have been distilled by Sarah into 12 exciting mini symposia that include complementary parts of all the submissions with a great balance of investigators from 10 different geographical bases . It is clearly going to be an outstanding meeting . We hope that you have time to relax and enjoy the wonderful cultural delights of Paris – while still getting to the meeting on time the next day! Also, the news that you have all been waiting for: the band is back together again – we once again have The Featles (European tour) which will be on Friday night after the Presidential Address . Enjoy the entertainment that will include some songs from my hometown of Liverpool . On behalf of the SRI Council, Program Committee and Staff, thank you all for attending the outstanding meeting that we have planned for you, so celebrate and connect with your colleagues and friends at SRI . Yours, Murray Mitchell, DPhil, DSc SRI President, 2018-2019 March 12 – 16, 2019 • Palais des Congrès de Paris, Paris, France 1 2019 Program Committee Program Committee Chair 2019 Program Director Emre Seli, MD Sarah England, PhD Yale School of Medicine Washington University School of Medicine Elizabeth Ann Bonney, MD, MPH Murray D. Mitchell, DPhil, DSc University of Vermont Queensland University of Technology Irina Burd, MD, PhD Leslie Myatt, PhD, FRCOG Johns Hopkins University Oregon Health and Science University Marilyn J. Cipolla, PhD Bo Rueda, PhD University of Vermont MGH / Harvard Medical School Charles Ducsay, PhD Floor Spaans, PhD Loma Linda University University of Alberta Thomas Jansson, MD, PhD James Segars, MD University of Colorado Johns Hopkins University School of Medicine 2 SOCIETY FOR REPRODUCTIVE INVESTIGATION • 66th Annual Scientific Meeting General Meeting Information Meeting Description The SRI Annual Meeting gathers leading scientists and clinical investigators annually to share cutting-edge information in reproductive sciences and women’s health . The 66th Annual Meeting will feature an exciting lineup of distinguished speakers, 12 mini-symposia sessions, several new investigator events, career development sessions, and excellent scientific oral and poster presentations . Meeting Location Host Hotel Palais des Congrès de Paris Hyatt Regency Paris Étoile 2 Place de la Porte Maillot 3, Place du Général Kœnig 75853 Paris Cedex 17 Paris, 75017, FR Phone: +33 (0)1 40 68 22 22 Phone: +33 (0)1 40 68 12 34 Meeting Objectives • Provide attendees with state-of-the-art knowledge in the reproductive sciences and women’s health research fields . • Gain insight into future directions from critical analysis of investigative findings . • Distinguished lectures and symposia will provide a focused format that fosters more meaningful dialogue among clinicians and researchers . • Connect and network with international leaders who are advancing the scientific study of reproductive and women’s health . Target Audience Scientists and clinical investigators who conduct basic, translational and clinical investigation in reproductive sciences and women’s health . Authorship Policy All authors connected to a presentation and/or abstract must agree on all information contained in the presentation . Failure of an author to agree to the presentation format will lead to the presentation being withdrawn from the conference . An author who submits a presentation to the Annual Meeting must have intentions of attending, registering, and presenting at the meeting once the submission is accepted into the program . Repeated or consecutive last-minute cancellations by presenters may result in future submissions being denied . Photography Disclaimer By registering for the SRI Annual Meeting, you give consent to be photographed by SRI staff for purposes of advertising and public display . Session Recording and Photos Session content is copyright-protected by SRI . Recording of any session without the consent of SRI is prohibited . Any recording done with consent of SRI is for personal use only and cannot be reproduced or distributed . Please refrain from taking photos of the presenter or the presentations as it is disruptive and the flash is distracting . No Smoking Policy Smoking is not permitted during any SRI activity or event . Website For more information
Load more

Recommended publications
  • Australian Force Projection 1885–1985
    Chapter 2 Australian Force Projection 1885–1985 Australia was dependent on allies for the first 100 years of its military history. From 1885 until the end of participation in the Vietnam War in 1972, they underwrote Australian involvement in regional and international military emergencies and campaigns. The Australian armed forces found it difficult to project force when allies were not in a position to help. This difficulty increased risk at tactical tipping points in 1942 on the Kokoda Track during the New Guinea Campaign and in 1966 at the battle of Long Tan in Vietnam soon after Australia deployed an independent task force. On both occasions, Australian troops prevailed against the odds, thereby obviating major political and strategic embarrassment. From 1972 until 1985, Australia did not project significant military force regionally or internationally except for some Cold War maritime and air surveillance activities. By 1985, the nation aspired to self-reliant joint force projection in defence of Australia and its interests. The dispatch of a New South Wales contingent to Sudan in 1885 set the first benchmark for rapid deployment. There were more to follow. Australia was able to recruit, prepare and dispatch first contingents in about four weeks. Rapid deployment was not required during the Second World War. There was time for contingents to begin preparation in Australia, and then complete training and equipping after arrival and before the test of combat. During the Cold War, Australian Governments allowed less time for preparation in home bases. There was little or no preparation after arrival before employment. For Korea and Vietnam, the time to prepare for deployment returned to about four weeks.
    [Show full text]
  • Novel Insights in Commercial in Vitro Embryo Production in Cattle
    Novel insights in commercial in vitro embryo production in cattle Maaike Catteeuw Promoter: Prof. dr. Ann Van Soom Copromoters: Prof. dr. Joris Vermeesch, Dr. Katrien Smits Dissertation submitted to Ghent University in fulfilment of the requirements for the degree of Doctor of Philosophy (PhD) in Veterinary Sciences 2018 Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine Members of the examination committee Prof. dr. Herman Favoreel Chairman – Faculty of Veterinary Medicine, Ghent University, Belgium Prof. dr. Bjorn Heindryckx Faculty of Medicine and Health Sciences, Ghent University, Belgium Prof. dr. Luc Peelman Faculty of Veterinary Medicine, Ghent University, Belgium Prof. dr. Geert Opsomer Faculty of Veterinary Medicine, Ghent University, Belgium Dr. Erik Mullaart CRV BV, the Netherlands Dr. Karen Goossens Research institute for Agriculture, Fisheries and Food (ILVO), Belgium Funding Project G039214N: Chromosomal instability during early embryonic development: elucidating key mechanisms in a bovine model Printed by University Press, Zelzate TABLE OF CONTENTS LIST OF ABBREVIATIONS CHAPTER 1 GENERAL INTRODUCTION 7 1.1 ASSISTED REPRODUCTIVE TECHNOLOGIES IN CATTLE 9 1.2 COMMERCIAL IN VITRO EMBRYO PRODUCTION 11 1.3 QUALITY ASSESSMENT OF EMBRYONIC DEVELOPMENT 25 1.4 GENETIC DISORDERS AND CHROMOSOMAL ABNORMALITIES IN CATTLE 34 1.5 CHROMOSOMAL ABNORMALITIES IN HUMAN EMBRYOS AND THE BOVINE MODEL 35 1.5 REFERENCES 37 CHAPTER 2 AIMS OF THE STUDY 51 CHAPTER 3 HOLDING IMMATURE BOVINE OOCYTES IN A COMMERCIAL
    [Show full text]
  • Government Gazette
    No. 24 1253 THE SOUTH AUSTRALIAN GOVERNMENT GAZETTE www.governmentgazette.sa.gov.au PUBLISHED BY AUTHORITY ALL PUBLIC ACTS appearing in this GAZETTE are to be considered official, and obeyed as such ADELAIDE, THURSDAY, 15 APRIL 2010 CONTENTS Page Appointments, Resignations, Etc............................................. 1254 Corporations and District Councils—Notices ......................... 1271 Crown Lands Act 1929—Notice ............................................. 1254 Fisheries Management Act 2007—Notices ............................. 1254 Harbors and Navigation Act 199—Notices............................. 1256 Housing Improvement Act 1940—Notices ............................. 1257 Liquor Licensing Act 1997—Notices...................................... 1258 Mining Act 1971—Notices ..................................................... 1262 National Electricity Law—Notice ........................................... 1263 Petroleum and Geothermal Energy Act 2000—Notice............ 1263 Private Advertisement ............................................................. 1271 Public Trustee Office—Administration of Estates .................. 1271 REGULATION Liquor Licensing Act 1997 (No. 25 of 2010) ...................... 1268 Retention of Title .................................................................... 1254 Roads (Opening and Closing) Act 1991—Notices.................. 1264 Unclaimed Moneys Act 1891—Notices.................................. 1272 Water Mains and Sewers—Mains Laid, Replaced, Etc........... 1264 GOVERNMENT GAZETTE
    [Show full text]
  • 2123 Genes Regulating Implantation and Fetal Development
    [Frontiers in Bioscience 11, 2123-2137, September 1, 2006] Genes regulating implantation and fetal development: a focus on mouse knockout models 1 1 2 ,3 Surendra Sharma , Shaun P. Murphy , and Eytan R. Barnea 1 Departments of Pediatrics and Pathology, Women and Infants’ Hospital of Rhode Island-Brown University, Providence, RI, 2 SIEP, the Society for the Investigation of Early Pregnancy, Cherry Hill, NJ and 3 Department of Obstetrics, Gynecology and Reproductive Sciences, UMDNJ/Robert Wood Johnson Medical School, Camden, NJ TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Endogeous gene expression 3.1. Gene expression in blastocyst implantation 3.2. Gene expression (silencing) in the embryo 4. Mouse knockout models of reproductive-related genes 4.1. Cytokines 4.2. Cyclooxygenase-2 4.3. Insulin-like growth factor system 4.4. Matrix metalloproteinase system 4.5. Transcription factors involved in placental development 4.6. Indolamine-2,3-dioxygenase 5. Conclusions 6. Acknowledgements 7. References 1. ABSTRACT 2. INTRODUCTION Timely and efficient regulation of blastocyst Mammalian reproduction represents a highly implantation and fetal growth are essential for the orchestrated and intricate process. The spatial and successful reproduction of viviparous mammals. temporal regulation of a fetal-maternal crosstalk is required Disruptions in this regulation can result in a wide variety of for a successful pregnancy (1-5). After fertilization, the human gestational complications including infertility, developing blastocyst must invade and establish itself in the spontaneous abortion, fetal growth restriction, and maternal endometrium, from which it will eventually gain premature delivery. The role of several groups of factors, the crucial protection and nourishment required for including cytokines, hormones, transcription factors, extra- development throughout gestation.
    [Show full text]
  • Australia's Joint Approach Past, Present and Future
    Australia’s Joint Approach Past, Present and Future Joint Studies Paper Series No. 1 Tim McKenna & Tim McKay This page is intentionally blank AUSTRALIA’S JOINT APPROACH PAST, PRESENT AND FUTURE by Tim McKenna & Tim McKay Foreword Welcome to Defence’s Joint Studies Paper Series, launched as we continue the strategic shift towards the Australian Defence Force (ADF) being a more integrated joint force. This series aims to broaden and deepen our ideas about joint and focus our vision through a single warfighting lens. The ADF’s activities have not existed this coherently in the joint context for quite some time. With the innovative ideas presented in these pages and those of future submissions, we are aiming to provoke debate on strategy-led and evidence-based ideas for the potent, agile and capable joint future force. The simple nature of ‘joint’—‘shared, held, or made by two or more together’—means it cannot occur in splendid isolation. We need to draw on experts and information sources both from within the Department of Defence and beyond; from Core Agencies, academia, industry and our allied partners. You are the experts within your domains; we respect that, and need your engagement to tell a full story. We encourage the submission of detailed research papers examining the elements of Australian Defence ‘jointness’—officially defined as ‘activities, operations and organisations in which elements of at least two Services participate’, and which is reliant upon support from the Australian Public Service, industry and other government agencies. This series expands on the success of the three Services, which have each published research papers that have enhanced ADF understanding and practice in the sea, land, air and space domains.
    [Show full text]
  • United States Patent 19 11 Patent Number: 5,646,003 Barnea Et Al
    US005646003A United States Patent 19 11 Patent Number: 5,646,003 Barnea et al. 45 Date of Patent: Jul. 8, 1997 54 PREIMPLANTATION FACTOR Collier M, O'Neill C, Ammit AJ, Saunders DM, Biochemi cal and pharmacological characterization of human embryo 76) Inventors: Eytan R. Barnea, 1697 Lark La., -derived activating factor. Hum Reprod. 1988:3:993-998. Cherry Hill, N.J. 08003; Carolyn B. O'Neill C, Gidley-Baird AA, Amnit AJ. Saunders DM. Use Coulam, 11015 Bryar Lynn Ct., Fairfax of a bioassay for embryo-derived platelet activating factor Sta. Va., 22039 as a means of assessing quality and pregnancy potential of human embryos. Fertill Steril. 1987:47:967-975. 21 Appl. No.: 216,618 O'Neill C. Gidley-Baird AL, Pike AL, Porter RN, Sinosich MJ, Saunders DM. Maternal blood platelet physiology and (22 Filed: Mar 23, 1994 luteal phase endocrinology as a means of monitoring preand (51 int. Cl. ................... G01N 33/53 postimplantation embryo viability following in vitro fertili zation. J. Vitro Fertil Embryo Transfer. 1985:2:59-65. 52 U.S. Cl. ........................ 435/7.24; 435/723; 435/806; O'Neill C, Collier M. Saunders DM. Embryo-derived plate 436/501; 436/510 let activating factor: its diagnosis and therapeutic future. 58 Field of Search ................................ 435/723, 7.24, Ann NY Acad Sci. 1988:541:398-403. 435/806; 436/501, 510 Smart YC, Roberts TK, Clancy RL, Cripps AW. Early 56 References Cited pregnancy factor: its role in mammalian reproduction-re search review. Ferti Steril. 1981:35:397-403. PUBLICATIONS Chen C. Jones WR, Bastin F.
    [Show full text]
  • (PIF) Protects Cultured Embryos Against Oxidative Stress: Relevance for Recurrent Pregnancy Loss (RPL) Therapy
    www.impactjournals.com/oncotarget/ Oncotarget, 2017, Vol. 8, (No. 20), pp: 32419-32432 Research Paper: Autophagy and Cell Death PreImplantation factor (PIF) protects cultured embryos against oxidative stress: relevance for recurrent pregnancy loss (RPL) therapy Lindsay F. Goodale1,6, Soren Hayrabedyan2, Krassimira Todorova2, Roumen Roussev3, Sivakumar Ramu3,8, Christopher Stamatkin3,9, Carolyn B. Coulam3, Eytan R. Barnea4,5,* and Robert O. Gilbert1,7,* 1 Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA 2 Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences, Sofia, Bulgaria 3 CARI Reproductive Institute, Chicago, IL, USA 4 BioIncept, LLC, Cherry Hill, NJ, USA 5 Society for the Investigation of Early Pregnancy (SIEP), Cherry Hill, NJ, USA 6 Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, CA, USA 7 Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies 8 Promigen Life Sciences, Downers Grove, IL, USA 9 Therapeutic Validation Core, Indiana University Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA * These authors have contributed equally to this work Correspondence to: Eytan R. Barnea, email: [email protected] Keywords: recurrent pregnancy loss, preImplantation factor (PIF), oxidative stress, PDI, embryo, Autophagy Received: December 05, 2016 Accepted: February 22, 2017 Published: March 08, 2017 Copyright: Goodale et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Recurrent pregnancy loss (RPL) affects 2-3% of couples.
    [Show full text]
  • Downloaded from Bioscientifica.Com at 09/25/2021 05:16:29PM Via Free Access
    REPRODUCTIONREVIEW The embryonic stress response to in vitro culture: insight from genomic analysis Gael Cagnone and Marc-André Sirard Département des Sciences Animales Pavillon des services, Université Laval, Quebec, QC, Canada Correspondence should be addressed to G Cagnone; Email: [email protected] Abstract Recent genomic studies have shed light on the impact of in vitro culture (IVC) on embryonic homeostasis and the differential gene expression profiles associated with lower developmental competence. Consistently, the embryonic stress responses to IVC conditions correlate with transcriptomic changes in pathways related to energetic metabolism, extracellular matrix remodelling and inflammatory signalling. These changes appear to result from a developmental adaptation that enhances a Warburg-like effect known to occur naturally during blastulation. First discovered in cancer cells, the Warburg effect (increased glycolysis under aerobic conditions) is thought to result from mitochondrial dysfunction. In the case of IVC embryos, culture conditions may interfere with mitochondrial maturation and oxidative phosphorylation, forcing cells to rely on glycolysis in order to maintain energetic homeostasis. While beneficial in the short term, such adaptations may lead to epigenetic changes with potential long-term effects on implantation, foetal growth and post-natal health. We conclude that lessening the detrimental effects of IVC on mitochondrial activity would lead to significantly improved embryo quality. Reproduction (2016) 152 R247–R261
    [Show full text]
  • YALE OBSTETRICAL and GYNECOLOGICAL SOCIETY YOGS Spring 2012 Volume 5
    YALE OBSTETRICAL AND GYNECOLOGICAL SOCIETY YOGS Spring 2012 Volume 5 THE JOURNAL FOR ALUMNI AND FRIENDS OF YALE OB/GYN THE JOURNAL FOR ALUMNI AND FRIENDS OF YALE OB/GYN 2011 YOGS Alumni & Friends Contributors Editor-In-Chief – Mary Jane Minkin, MD Managing Editor – Dianna Malvey The YOGS Journal is published yearly by the Yale University Department of Obstetrics, Gynecology and Reproductive Sciences, PO Box 208063, FMB 337, New Haven, Connecticut 06520-8063. Tel: 203-737-4593; Fax: 203-737-1883 http://medicine.yale.edu/obgyn/yogs/index.aspx Copyright © 2012 Yale University School of Medicine. All Rights Reserved. Cover Photo: Yale University, Terry DaGradi, Yale Photo & Design. All Rights Reserved. I THE JOURNAL FOR ALUMNI AND FRIENDS OF YALE OB/GYN TABLE OF CONTENTS Editor’s Note 2 Historical Note 3 Residents’ Research Day Visiting Professor Grand Rounds 4 Other Selected Grand Rounds Presentations 6 Residents’ Research Day - Abstracts of Resident Presentations 23 Abstracts from Recent Scientific Meetings 29 The Year in Review 38 Photo Highlights 46 News Items 50 Forms 59 1 YALE OBSTETRICAL AND GYNECOLOGICAL SOCIETY EDITOR’S NOTE Another momentous year Of course, we will update you on the research here in New Haven! As and clinical progress of our sections and the prog- most of you know, de- ress of our trainees, who continue to go out into spite the many charms the world and promote our field. of New Haven, Dr. Lock- wood has left us to as- We hope that many of you will be joining us here sume the Dean’s post at in New Haven on May 12, when we celebrate The Ohio State University the career of Yale’s first female resident, Dr.
    [Show full text]
  • Insight Into Preimplantation Factor (PIF*) Mechanism for Embryo
    Insight into PreImplantation Factor (PIF*) Mechanism for Embryo Protection and Development: Target Oxidative Stress and Protein Misfolding (PDI and HSP) through Essential RIPK Binding Site Eytan R. Barnea1,2,3*, David M. Lubman4, Yan-Hui Liu4, Victor Absalon-Medina5, Soren Hayrabedyan6, Krassimira Todorova6, Robert O. Gilbert5, Joy Guingab7, Timothy J. Barder8 1 Research & Development, SIEP The Society for the Investigation of Early Pregnancy, Cherry Hill, New Jersey, United States of America, 2 Research & Development, BioIncept, LLC, Cherry Hill, New Jersey, United States of America, 3 Department of Obstetrics, Gynecology and Reproduction, UMDNJ-Robert Wood Johnson Medical School, Camden, New Jersey, United States of America, 4 Department Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, United States of America, 5 Reproductive Medicine, Cornell University, College of Veterinary Medicine, Ithaca, New York, United States of America, 6 Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences, Sofia, Bulgaria, 7 Chemical Biology and Proteomics, Banyan Biomarkers, Alachua, Florida, United States of America, 8 Research & Development, Eprogen, Downers Grove, Illinois, United States of America Abstract Background: Endogenous PIF, upon which embryo development is dependent, is secreted only by viable mammalian embryos, and absent in non-viable ones. Synthetic PIF (sPIF) administration promotes singly cultured embryos development and protects against their demise caused by embryo-toxic serum. To identify and characterize critical sPIF-embryo protein interactions novel biochemical and bio-analytical methods were specifically devised. Methods: FITC-PIF uptake/binding by cultured murine and equine embryos was examined and compared with scrambled FITC-PIF (control). Murine embryo (d10) lysates were fractionated by reversed-phase HPLC, fractions printed onto microarray slides and probed with Biotin-PIF, IDE and Kv1.3 antibodies, using fluorescence detection.
    [Show full text]
  • Final Program
    FINAL PROGRAM — From Innovation to Impact — Society for Reproductive Investigation 66th Annual Scientific Meeting March 12 - 16, 2019 PARIS, FRANCE The SRI 66th Annual Scientific Meeting has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) March 12 – 16, 2019 • Palais des Congrès de Paris, Paris, France 1 Table of Contents Message from the SRI President . 1 2019 Program Committee . 2 General Meeting Information . 3 Meeting Attendance Code of Conduct Policy . 4 Schedule-at-a-Glance . 5 Meeting Information and Social Events . 6 Exhibitors . 7 Palais des Congrès de Paris Floor Plan . 8 Hyatt Regency Paris Étoile Floor Plan . 9 Continuing Medical Education Information . 11 Scientific Program . 12 Thank You to Our 2019 Poster Judges . 55 SRI Grant Opportunities . .56 2019 Awards . 57 About SRI . .59 . SRI Council & Staff . 61 Poster Guide . 62 Oral and Poster Abstract Author Index . 108 Notes . 133 SRI Thanks Its 2019 Supporters . Inside Back Cover Save the Date: SRI 2020 Annual Meeting . Back Cover SRI 66th Annual Scientific Meeting Venue SRI 66th Annual Scientific Meeting Host Hotel Palais des Congrès de Paris Hyatt Regency Paris Étoile 2 Place de la Porte Maillot 3, Place du Général Kœnig 75853 Paris Cedex 17 Paris, 75017, FR Phone: +33 (0)1 40 68 22 22 Phone: +33 (0)1 40 68 12 34 Future SRI Annual Scientific Meetings SRI 67th Annual Scientific Meeting • Vancouver, BC, Canada • March 10 – 14, 2020 SRI 68th Annual Scientific Meeting • Boston, MA • March 23 – 27, 2021 SRI 69th Annual Scientific Meeting • Denver, CO • March 15 – 19, 2022 SRI 70th Annual Scientific Meeting • Brisbane, Australia • March 21 - 25, 2023 Society for Reproductive Investigation 555 East Wells Street, Suite 1100 Milwaukee, WI 53202-3823 Phone: +1-414-918-9888 Fax: +1-414-276-3349 Email: info@sri-online .org Website: www .sri-online .org © Society for Reproductive Investigation .
    [Show full text]
  • Preimplantation Factor Modulates Trophoblastic Invasion Throughout
    Santos et al. Reproductive Biology and Endocrinology (2021) 19:96 https://doi.org/10.1186/s12958-021-00774-5 RESEARCH Open Access Preimplantation factor modulates trophoblastic invasion throughout the decidualization of human endometrial stromal cells Esther Dos Santos1,2,3, Hadia Moindjie4, Valérie Sérazin1,2,3, Lucie Arnould1,2, Yoann Rodriguez1,2, Khadija Fathallah5, Eytan R. Barnea6,7, François Vialard1,2,3 and Marie-Noëlle Dieudonné1,2,8* Abstract Background: Successful human embryo implantation requires the differentiation of endometrial stromal cells (ESCs) into decidual cells during a process called decidualization. ESCs express specific markers of decidualization, including prolactin, insulin-like growth factor-binding protein-1 (IGFBP-1), and connexin-43. Decidual cells also control of trophoblast invasion by secreting various factors, such as matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases. Preimplantation factor (PIF) is a recently identified, embryo-derived peptide with activities at the fetal-maternal interface. It creates a favorable pro-inflammatory environment in human endometrium and directly controls placental development by increasing the human trophoblastic cells’ ability to invade the endometrium. We hypothesized that PIF’s effects on the endometrium counteract its pro-invasive effects. Methods: We tested sPIF effect on the expression of three decidualization markers by RT-qPCR and/or immunochemiluminescence assay. We examined sPIF effect on human ESC migration by performing an in vitro wound healing assay. We analyzed sPIF effect on endometrial control of human trophoblast invasion by performing a zymography and an invasion assay. Results: Firstly, we found that a synthetic analog of PIF (sPIF) significantly upregulates the mRNA expression of IGFBP-1 and connexin-43, and prolactin secretion in ESCs - suggesting a pro-differentiation effect.
    [Show full text]